Skip to main content
. 2022 Aug 1;100(8):626–641.

Table4.Spirometricand plethysmographicprofilesofpatientswithrheumatoidarthritis(RA):Algiers(Algeria):2018-2019.

Data

Outcome

Total sample(n=59)

ACPA - (n=33)

ACPA + (n=26)

p-value

FVC

33 (55.9)

18 (54.5)

15 (57.7)

.8058

FEV1

32 (54.2)

16 (48.5)

16 (61.5)

.3197

FEV1/FVC (OVI)

13 (22.0)

3 (9.1)

10 (38.5)

.0069 *

z-score < -1.645

MMEF

9 (15.3)

1 (3.0)

8 (30.8)

.032 *

SVC

38 (64.4)

21 (63.6)

17 (65.4)

.8860

FRC

2 (3.4)

2 (6.1)

0 (0.0)

.2000

RV

2 (3.4)

2 (6.1)

0 (0.0)

.2000

IC

30 (50.8)

18 (54.5)

12 (46.2)

.5267

TLC (RVI)

21 (35.6)

15 (45.5)

6 (23.1)

.0745

RV (lung-hyperinflation)

14 (23.7)

3 (9.1)

11 (42.3)

.0029 *

TLC

9 (15.3)

3 (9.1)

6 (23.1)

.1377

z-score > +1.645

FRC

13 (22.0)

3 (9.1)

10 (38.5)

.0069 *

IC

0 (0.0)

0 (0.0)

0 (0.0)

-

RV/TLC

33 (55.9)

17 (51.5)

16 (61.5)

.4424

Ventilatory impairments

Mixed ventilatory impairment

2 (3.4)

1 (3.0)

1 (3.8)

.8654

Nonspecific ventilatory impairment

4 (6.8)

2 (6.1)

2 (7.7)

.8086

Classifications of OVI

Moderate

8 (13.6)

2 (6.1)

6 (23.1)

0.0585

Severe

5 (8.5)

1 (3.0)

4 (15.4)

0.0894

Classifications of RVI

Mild

8 (13.6)

7 (21.2)

1 (3.8)

0.0524

Moderate

13 (22.0)

8 (24.2)

5 (19.2)

0.3226

OVI: Obstructive Ventilatory Impairment. RVI: Restrictive Ventilatory Impairment. For the remaining abbreviations, see table 3. Data were number (%). * p-value < 0.05: 2 sided Chi-square test: comparison between the 2 groups. Notes: 1. ACPA - group: among the 3 subjects with an OVI, 1 had lung-hyperinflation, and among the 3 subjects with lung-hyperinflation, 1 had an OVI. 2. ACPA + group: among the 10 subjects with an OVI, 9 had lung-hyperinflation, and among the 11 subjects with lung-hyperinflation, 9 had an OVI